@dizzan The SP was always going to go down now that traders know that no curve ball is coming and another 60 day wait will now happen. He is not right in randomly stating as fact that the FDA must have issues with the viability of the trial. That's pretty blatant down ramping.
Good announcement, the SP will do what it does until IND approval, then $3+ in short order before venturing even higher, especially after Mozz's information about how few Aus biotechs have gotten an IND in recent years, we will suddenly be substantially de-risked and on radar.
Ann: IND QUESTIONS RECEIVED FROM US FDA, page-40
-
- There are more pages in this discussion • 350 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
0.005(2.50%) |
Mkt cap ! $71.79M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 20.5¢ | 19.5¢ | $203.7K | 1.013M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 21749 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 24639 | 2 |
View Market Depth
| Last trade - 16.10pm 16/10/2024 (20 minute delay) ? |
| PAR (ASX) Chart |